Lars Moller Pedersen
Overview
Explore the profile of Lars Moller Pedersen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
1210
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bennedsen T, Simonsen M, Jensen P, Brown P, Josefsson P, Khurana A, et al.
Eur J Haematol
. 2025 Jan;
PMID: 39786332
The development of new first-line treatments for patients with follicular lymphoma (FL) is becoming increasingly challenging due to already excellent survival outcomes. The present study investigated the outcomes of patients...
2.
Breinholt M, Schejbel L, Gang A, Christensen I, Nielsen T, Moller Pedersen L, et al.
Eur J Haematol
. 2024 Dec;
114(3):573-579.
PMID: 39691999
Introduction: Large B-cell lymphoma (LBCL) taxonomy has moved in the direction of a molecular classification, but further clinical experience is needed. We present high-risk gene mutations, which predict outcome in...
3.
Ostergaard S, Munksgaard L, Nielsen T, Hammer T, Moller Pedersen L, Pedersen M, et al.
EJHaem
. 2024 Dec;
5(6):1269-1273.
PMID: 39691270
Introduction: Extramedullary disease (EMD) is a rare manifestation of Waldenström macroglobulinemia (WM), and its clinical and prognostic implications are poorly understood. Methods: In this single-center study, we investigated the clinical...
4.
Al-Shahrestani F, Al-Khafaf A, Asheer Z, Jelicic J, Chanchiri I, Blocher C, et al.
Laryngoscope
. 2024 Dec;
135(4):1391-1400.
PMID: 39688162
Objective: We examined the epidemiology of parotid gland lymphomas (PGL), the incidence, survival rates, clinical features, and association with primary Sjögren's syndrome (pSS). Methods: This retrospective nationwide cohort study analyzed...
5.
Hersby D, Schejbel L, Breinholt M, Hogdall E, Norgaard P, Nielsen T, et al.
Ann Hematol
. 2024 Dec;
103(12):5835-5848.
PMID: 39644335
Introduction: Large B-cell lymphoma (LBCL) exhibits striking clinical and molecular heterogeneity. New approaches have emerged to explore tumor heterogeneity and classify LBCL into biological categories. Consequently, the informational requirements from...
6.
Tolley Dr E, Tolley E, Nielsen T, Hersby D, Ostergaard S, Rasmussen M, et al.
Blood Adv
. 2024 Nov;
9(4):893-905.
PMID: 39571170
Secondary central nervous system lymphoma (SCNSL) is a rare manifestation of diffuse large B-cell lymphoma (DLBCL) with a poor prognosis. We present updated data from a nationwide study on the...
7.
Al-Shahrestani F, Al-Khafaf A, Asheer Z, Jelicic J, Chanchiri I, Blocher C, et al.
Eur Arch Otorhinolaryngol
. 2024 Oct;
PMID: 39379648
Objective: This study explores the epidemiology, incidence, and survival outcomes associated with lymphomas of the submandibular gland (SMG) and examines the influence of autoimmune diseases on these parameters. Methods: This...
8.
Enemark M, Hemmingsen J, Andersen M, Hybel T, Bjorn M, Josefsson P, et al.
Blood Cancer J
. 2024 Sep;
14(1):167.
PMID: 39349431
No abstract available.
9.
Micas Pedersen S, Hersby D, Jarden M, Nielsen T, Gang A, Bjorn Poulsen C, et al.
Heliyon
. 2024 Jul;
10(11):e31915.
PMID: 38961916
Advancements in lymphoma treatment have increased the number of long-term survivors who may experience late effects such as impaired sexual function and testosterone deficiency. The aim of this review was...
10.
Thau S, Bjorn Poulsen C, Brieghel C, Larsen M, Wiese L, Nielsen X, et al.
Ann Hematol
. 2024 Apr;
103(8):3053-3060.
PMID: 38634916
Patients with chronic lymphocytic leukemia (CLL) are at high risk of developing severe COVID-19. The present study was undertaken to elucidate COVID-19 related morbidity and mortality in CLL patients treated...